FEMSelect

Surgical Devices · Newark, DE · Founded 2012 · Privately Held (backing)

Developer of medical devices designed to treat pelvic organ prolapse disease in women. FEMSelect is based in Newark, DE and was founded in 2012. It was valued at $17 million at its later-stage round in Sep 2022, the last priced event on record. It has raised $12.2 million across 1 recorded round; the latest was an accelerator round in Jan 2018.

PMV mark · valuation
$17.0M
Oct 2026
Priced at
its later-stage round
Sep 2022
Total raised
$12.2M
Last round
Accelerator/Incubator
Jan 2018
What is FEMSelect worth?
$17.0MPrivateMarketView mark · Oct 2026

Valued at $17.0M at its later-stage round, Sep 2022. Nothing has traded since.

Free account
More of FEMSelect with a free account
  • ·The complete investor list: 21 names
  • ·Watch FEMSelect: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

FEMSelect funding history

1 rounds
DateRoundRaisedPost-money
Jan 2018Accelerator/Incubator—▮
Unlock post-money valuations

Membership and data by Private Market View

FEMSelect valuation

FEMSelect was valued at $17 million at its later-stage round in Sep 2022. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has FEMSelect raised?

FEMSelect has raised $12.2 million in total; 1 of its rounds is on record. The most recent was an accelerator round in Jan 2018.

Comparable companies

Comparable surgical devices names by valuation on PrivateMarketView: Imperative Care ($1.6 billion), SpyGlass Pharma (NAS: SGP) ($511 million) and Eximis Surgical ($18.7 million).

How FEMSelect's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For FEMSelect, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about FEMSelect

What is FEMSelect worth?
FEMSelect is valued at $17.0M as of Oct 2026. Valued at $17.0M at its later-stage round, Sep 2022. Nothing has traded since.
How much has FEMSelect raised?
FEMSelect has raised $12.2M in total funding across 1 recorded rounds.
When did FEMSelect last raise?
FEMSelect last raised in Jan 2018 (Accelerator/Incubator).